Segment Reporting (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($) Segment	Dec. 31, 2023 USD ($)
Segment Reporting, Revenue Reconciling Item [Line Items]
Number of reportable segments | Segment	1
Segment Reporting Information, Profit (Loss) [Abstract]
Revenue	$ 8,740	$ 8,864
Gross Profit	5,676	4,983
Operating expenses:
Total operating expenses	16,664	22,613
Stock Based Compensation	478	670
Net loss	(11,165)	(20,209)
Fluid Overload [Member]
Segment Reporting Information, Profit (Loss) [Abstract]
Revenue	8,740	8,864
Gross Profit	$ 5,676	$ 4,983
Gross profit %	64.90%	56.20%
Operating expenses:
General and administrative	$ 5,637	$ 6,832
Sales and Marketing	6,254	8,709
Development	1,645	3,655
Clinical, Quality, Regulatory	2,650	2,747
Total operating expenses	16,186	21,943
Stock Based Compensation	478	670
Other Expenses	177	2,579
Net loss	$ (11,165)	$ (20,209)